508: Readmission Following Discharge on Labetalol or Nifedipine for Management of Hypertensive Disorders of Pregnancy

American Journal of Obstetrics and Gynecology - United States
doi 10.1016/j.ajog.2018.11.530
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparative Study of Labetalol and Nifedipine in Management of Hypertensive Disorders in Pregnancy

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2016English

Comparison of Maternal Outcome in Patients Treated With Methyldopa and Labetalol in the Management of Hypertensive Disorders of Pregnancy

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

Hypertensive Disorders of Pregnancy

Hypertension
Internal Medicine
2018English

The Hypertensive Disorders of Pregnancy

JAMA - Journal of the American Medical Association
Medicine
1954English

The Hypertensive Disorders of Pregnancy

BMJ
1995English

Comparison of Intravenous Labetalol and Oral Nifedipine in Management of Blood Pressure in Patients With Severe Pregnancy Induced Hypertension

Journal of University Medical & Dental College
2019English

A Randomized Trial of Intravenous Labetalol and Oral Nifedipine in Severe Pregnancy Induced Hypertension

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2012English

Oral Labetalol Versus Oral Nifedipine for the Management of Postpartum Hypertension a Randomized Control Trial

Pakistan Journal of Medical Sciences
Medicine
2019English

Hypertensive Disorders of Pregnancy and Future Cardiovascular Health

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy